Table 2. Intervention related Major complications.
Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | |
---|---|---|---|---|---|
Diagnosis | PA-VSD | PA-VSD | PA-VSD | PA-VSD | PA-IVS |
Origin of duct | Underside of a.a. | DAO | Underside of a.a. | TBC | Underside of a.a |
Vascular access | Fem. A | Fem. A | axil. A | Fem. A | axil. A |
DCI | 0.62 (IV) | 0 (I) | 0.54 (IV) | 0.52 (IV) | 0.62 (IV) |
Complications | S. Thrombosis | S. Thrombosis | Vessel damage | S. Thrombosis | S. Thrombosis |
Thrombophilia screen | FFVLM | FFVLM | Not tested | Not tested | Not tested |
Outcome | MBT shunt | Glenn | Retardation | MBT shunt | MBT shunt |
PA, pulmonary atresia; VSD, ventricular septum defect; IVS, intact ventricular septum; Underside of a.a., underside of aortic arch; DAO, descending aorta; TBC, truncus brachiocephalicus; DCI, ductal curvature index; axil. A, axillary artery; Fem. A, femoral artery; mBT, modified Blalock-Taussig shunt; S. Thrombosis, Stent thrombosis; FFVLM, familial factor V Leiden mutation.